Profile data is unavailable for this security.
About the company
Utah Medical Products, Inc. is engaged in the business of producing medical services. The Company markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit (NICU), the labor and delivery (L&D) department and the women's health center in hospitals, as well as medical devices sold to outpatient clinics and physician's offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device used immediately after birth to clear neonatal respiratory passages and reduce exposure to potential infections. AROM-CO is a finger cover with a prong designed to rupture maternal membranes with less patient pain and anxiety.
- Revenue in USD (TTM)49.04m
- Net income in USD16.38m
- Incorporated1978
- Employees169.00
- LocationUtah Medical Products Inc7043 S 300 WestMIDVALE 84047United StatesUSA
- Phone+1 (801) 566-1200
- Fax+1 (801) 566-7305
- Websitehttp://www.utahmed.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accuray Inc | 430.55m | -21.49m | 172.68m | 1.02k | -- | 4.20 | -- | 0.4011 | -0.2197 | -0.2197 | 4.42 | 0.4139 | 0.9178 | 1.86 | 5.72 | 420,462.90 | -4.58 | -1.45 | -7.84 | -2.48 | 33.06 | 37.86 | -4.99 | -1.62 | 0.778 | -0.3857 | 0.8086 | -- | 4.12 | 2.03 | -73.56 | -- | 13.92 | -- |
| CVRx Inc | 42.09m | -52.01m | 187.67m | 200.00 | -- | 2.83 | -- | 4.46 | -2.48 | -2.48 | 2.01 | 3.07 | 0.3678 | 0.6781 | 5.64 | 210,430.00 | -45.45 | -- | -48.95 | -- | 84.45 | -- | -123.58 | -- | 10.87 | -21.11 | 0.3064 | -- | 74.89 | -- | 0.5528 | -- | -- | -- |
| Neuropace Inc | 69.07m | -31.51m | 188.14m | 171.00 | -- | 13.10 | -- | 2.72 | -1.18 | -1.18 | 2.59 | 0.4994 | 0.6735 | 1.62 | 6.63 | 403,935.70 | -30.72 | -- | -34.60 | -- | 73.97 | -- | -45.61 | -- | 5.56 | -4.67 | 0.8019 | -- | 43.72 | -- | 30.00 | -- | -- | -- |
| Delcath Systems Inc | 4.61m | -49.79m | 190.61m | 76.00 | -- | 11.94 | -- | 41.37 | -2.65 | -2.65 | 0.2357 | 0.5747 | 0.1382 | 0.4545 | 4.56 | 60,618.42 | -149.30 | -116.57 | -249.28 | -243.21 | 70.54 | 71.02 | -1,080.73 | -1,235.37 | 2.25 | -42.25 | 0.3348 | -- | -24.05 | -9.53 | -30.60 | -- | -5.26 | -- |
| Inogen Inc | 321.52m | -96.68m | 194.04m | 834.00 | -- | 1.01 | -- | 0.6035 | -4.15 | -4.15 | 13.81 | 8.15 | 0.917 | 6.03 | 6.83 | 385,519.20 | -27.57 | -8.23 | -34.28 | -9.53 | 40.54 | 44.54 | -30.07 | -10.31 | 2.36 | -- | 0.00 | -- | -16.32 | -2.49 | -22.30 | -- | 26.34 | -- |
| Edap Tms SA (ADR) | 65.79m | -19.82m | 194.62m | 307.00 | -- | 3.38 | -- | 2.96 | -0.5353 | -0.5353 | 1.78 | 1.55 | 0.6377 | 2.39 | 3.53 | 214,302.00 | -19.21 | -6.62 | -26.95 | -9.22 | 40.91 | 43.23 | -30.12 | -9.59 | 2.00 | -- | 0.0757 | -- | 9.64 | 9.05 | -622.06 | -- | 32.75 | -- |
| Butterfly Network Inc | 68.08m | -121.92m | 201.52m | 225.00 | -- | 0.9875 | -- | 2.96 | -0.5893 | -0.5893 | 0.329 | 0.9685 | 0.2045 | 0.6954 | 4.97 | 302,577.80 | -36.61 | -- | -42.07 | -- | 26.50 | -- | -179.08 | -- | 3.34 | -- | 0.00 | -- | -10.21 | -- | 20.76 | -- | -- | -- |
| Outset Medical Inc | 125.08m | -168.77m | 210.51m | 480.00 | -- | 2.26 | -- | 1.68 | -3.38 | -3.38 | 2.50 | 1.80 | 0.3529 | 1.82 | 3.53 | 260,577.10 | -47.61 | -41.40 | -54.98 | -47.29 | 24.61 | 5.71 | -134.93 | -159.05 | 5.32 | -32.13 | 0.6786 | -- | 13.00 | 130.43 | -6.04 | -- | 14.27 | -- |
| Semler Scientific Inc | 65.88m | 21.69m | 211.06m | 92.00 | 10.75 | 2.65 | 9.45 | 3.20 | 2.78 | 2.78 | 8.45 | 11.26 | 0.855 | 15.13 | 8.51 | 716,097.80 | 28.14 | 38.83 | 31.14 | 44.41 | 89.43 | 90.22 | 32.92 | 32.58 | 12.11 | -- | 0.00 | -- | 20.28 | 25.98 | 43.69 | 32.64 | -0.3821 | -- |
| Senseonics Holdings Inc | 23.30m | -80.59m | 233.59m | 132.00 | -- | 12.32 | -- | 10.03 | -0.1354 | -0.1354 | 0.039 | 0.1067 | 0.1635 | 2.51 | 6.51 | 176,515.20 | -56.55 | -73.65 | -66.90 | -106.97 | 12.93 | -40.41 | -345.89 | -649.86 | 3.70 | -11.13 | 0.4783 | -- | 36.62 | 3.43 | -142.49 | -- | -18.76 | -- |
| Utah Medical Products, Inc. | 49.04m | 16.38m | 237.57m | 169.00 | 14.93 | 1.89 | 10.99 | 4.84 | 4.51 | 4.51 | 13.50 | 35.60 | 0.3727 | 2.09 | 13.24 | 290,201.20 | 12.44 | 12.69 | 13.02 | 13.19 | 59.05 | 61.57 | 33.39 | 30.51 | 17.89 | -- | 0.00 | 37.05 | -3.93 | 3.64 | 0.9834 | 1.65 | 9.71 | 1.86 |
| AngioDynamics, Inc. | 324.01m | -192.37m | 260.35m | 815.00 | -- | 1.20 | -- | 0.8035 | -4.78 | -4.78 | 8.10 | 5.41 | 0.7468 | 2.66 | 6.46 | 397,555.80 | -44.34 | -9.12 | -54.02 | -10.17 | 50.17 | 54.23 | -59.37 | -19.48 | 1.62 | -- | 0.00 | -- | 7.13 | 5.30 | -97.54 | -- | 3.55 | -- |
| Pulmonx Corp | 72.99m | -58.73m | 274.04m | 279.00 | -- | 2.48 | -- | 3.75 | -1.54 | -1.54 | 1.91 | 2.85 | 0.399 | 1.14 | 7.81 | 261,627.20 | -32.11 | -26.27 | -35.87 | -28.97 | 74.31 | 71.95 | -80.46 | -93.76 | 6.14 | -- | 0.252 | -- | 27.98 | 27.98 | -3.26 | -- | 20.62 | -- |
| Orchestra Biomed Holdings Inc | 2.22m | -51.64m | 282.73m | 56.00 | -- | 4.94 | -- | 127.59 | -1.47 | -1.47 | 0.063 | 1.60 | 0.0203 | 1.01 | 30.99 | 39,571.43 | -47.18 | -- | -52.58 | -- | 92.06 | -- | -2,330.46 | -- | 7.33 | -- | 0.00 | -- | -21.88 | -- | -37.91 | -- | -- | -- |
| Tactile Systems Technology Inc | 276.67m | 28.19m | 287.76m | 992.00 | 10.24 | 1.49 | 8.28 | 1.04 | 1.18 | 1.18 | 11.70 | 8.14 | 1.01 | 6.77 | 6.05 | 278,896.20 | 10.30 | 0.9015 | 12.18 | 1.09 | 49.98 | 49.10 | 10.19 | 0.8309 | 3.63 | -- | 0.128 | 0.00 | 11.20 | 13.81 | 259.60 | 33.91 | -23.62 | -- |
Data as of Jun 10 2024. Currency figures normalised to Utah Medical Products Inc's reporting currency: US Dollar USD
42.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 31 Mar 2024 | 385.39k | 10.74% |
| Renaissance Technologies LLCas of 31 Mar 2024 | 232.51k | 6.48% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 182.10k | 5.07% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 176.69k | 4.92% |
| Dimensional Fund Advisors LPas of 31 Mar 2024 | 161.61k | 4.50% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 80.66k | 2.25% |
| Ranger Investment Management LPas of 31 Mar 2024 | 80.45k | 2.24% |
| Geode Capital Management LLCas of 31 Mar 2024 | 73.68k | 2.05% |
| Brandes Investment Partners LPas of 31 Mar 2024 | 70.10k | 1.95% |
| Rice, Hall, James & Associates LLCas of 31 Mar 2024 | 64.61k | 1.80% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
